About
Growing blood stem cells for therapeutic use
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyStem Cell & Cellular Therapy
Team (15)
Anne Marinier
Anne Marinier
ExCellThera
team_member
Bernhard Gentner
Bernhard Gentner
ExCellThera
team_member
David Millette
David Millette
ExCellThera
team_member
Elizabeth Douville
Elizabeth Douville
ExCellThera
team_member
Guy Sauvageau
Guy Sauvageau
ExCellThera
team_member
Jean Proulx
Jean Proulx
ExCellThera
team_member
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
92
By Phase
PHASE1/PHASE2: 2PHASE1: 1PHASE2: 2
By Status
ACTIVE_NOT_RECRUITING: 3RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT04990323Lead Sponsor
US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies
PHASE1/PHASE2Recruiting
12 participants
Started: Dec 1, 2021 · Completed: Jun 1, 2027
NCT04594031Lead Sponsor
US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
PHASE1Withdrawn
Started: Jul 13, 2021 · Completed: Feb 2, 2024
NCT04103879Lead Sponsor
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
PHASE2Active, not recruiting
30 participants
Started: Nov 13, 2020 · Completed: Feb 28, 2026
NCT03913026Collaborator
UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia
PHASE2Active, not recruiting
30 participants
Started: Apr 1, 2019 · Completed: Oct 31, 2027
NCT03441958Collaborator
ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Mar 7, 2018 · Completed: Oct 17, 2025
Locations (1)
Headquarters
Montréal, QC, Canada
Map
Loading map...